UK becomes first in Europe to approve new once-daily weight loss pill

Britain's medicines regulator has today granted approval to orforglipron, marketed under the brand name Foundayo, positioning the UK as the first nation in Europe to greenlight this oral GLP-1 treatment for weight management and type 2 diabetes.The Medicines and Healthcare products Regulatory Agency confirmed the authorisation on Monday, marking a significant milestone for patients seeking alternatives to injectable weight-loss therapies.The once-daily tablet has been cleared for use by adults living with obesity, defined as a body mass index of 30 or greater, as well as those with a BMI between 27 and 30 who also have at least one weight-related health condition.The drug is intended to complement a reduced-calorie diet and greater...

Läs hela artikeln hos källan.